Pre-market hot trades in US stocks: Matinas Biopharma up 10.74% in pre-market; Jyong Biotech up 9.70% in pre-market

Tracking Unusual Activity
2025.11.20 13:11
portai
I'm PortAI, I can summarize articles.

Matinas Biopharma pre-market rose 10.74%; Jyong Biotech pre-market rose 9.70%; Sonder pre-market rose 110.53%; Mobile-Health Network Solutions pre-market rose 74.11%; PACS pre-market rose 50.03%

Popular Pre-Market Trades in US Stocks

Matinas Biopharma, up 10.74% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

Jyong Biotech, up 9.70% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

Top Gainers in Pre-Market US Stocks

Sonder, up 110.53% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

Mobile-Health Network Solutions, up 74.11% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.

PACS, up 50.03% in pre-market trading. Based on recent key news:

  1. On November 19, PACS Group released its third-quarter financial report, showing a year-on-year revenue increase of 36.5% to $3.93 billion, with net income reaching $131.7 million and strong cash flow. These positive financial data drove the stock price up.

  2. On November 19, analysts gave PACS stock a latest rating of "Buy," with a target price of $32. Despite high financial leverage and negative technical indicators, strong revenue growth and operational expansion support a positive market outlook.

  3. On November 17, PACS Group announced it would release its third-quarter financial report on November 19 and hold a conference call to discuss the results. This announcement attracted market attention and drove the stock price up. Industry expansion and financial growth support the stock price increase

Source: Tracking Unusual Activity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer